Skip to content
  • Sunday, 26 July 2026
  • 4:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Terray says TerraBind delivers 26x faster inference than Boltz-2 by skipping diffusion-based coordinate generation
Laboratory Automation & Robotics

Terray says TerraBind delivers 26x faster inference than Boltz-2 by skipping diffusion-based coordinate generation

Lana Keisha Mar 21, 2026 0

In a significant development for AI-driven drug discovery, Terray Therapeutics, a Los Angeles-area startup, has introduced TerraBind, a novel potency…

Read More
Clinical Diagnostics & Pathology

Lab Skills on the Rise, Says LinkedIn’s Latest Report

Reynand Amr Wu Mar 19, 2026 0

A groundbreaking analysis from LinkedIn’s latest "Skills on the Rise" report has unveiled a profound transformation in the competencies deemed…

Read More

Posts pagination

1 2
Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical LaboratoriesFDA Commissioner Marty Makary Resigns Amid Administration Pressure and Widespread CriticismBMS claims pharma’s most powerful AI supercomputer. How it stacks up to Lilly’s and Roche’s.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ